Screener
Icahn Enterprises IEP Pharma — Goodwill
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Icahn Enterprises in its filing.
Tagged under the XBRL concept us-gaap:Goodwill.
The source filing: Icahn Enterprises’s 10-Q, filed August 5, 2026.
- Filed
- Aug 4, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-090605
| Line item | June 30, 2026 / Gross / Carrying / Amount | June 30, 2026 / Accumulated / Impairment | June 30, 2026 / Net / Carrying / Value | December 31, 2025 / Gross / Carrying / Amount | December 31, 2025 / Accumulated / Impairment | December 31, 2025 / Net / Carrying / Value |
|---|---|---|---|---|---|---|
| Automotive | $337 | $(87) | $250 | $337 | $(87) | $250 |
| Food Packaging | 6 | — | 6 | 6 | — | 6 |
| Home Fashion | 23 | (3) | 20 | 24 | (3) | 21 |
| Pharma | 13 | — | 13 | 13 | — | 13 |
| $379 | $(90) | $289 | $380 | $(90) | $290 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Icahn Enterprises's pharma — goodwill?
- Icahn Enterprises (IEP) reported pharma — goodwill of $13M in Q2 2026.
- How has Icahn Enterprises's pharma — goodwill changed year-over-year?
- Icahn Enterprises's pharma — goodwill decreased by 0.0% year-over-year, from $13M to $13M.
- What is the long-term trend for Icahn Enterprises's pharma — goodwill?
- Over 4 years (2021 to 2025), Icahn Enterprises's pharma — goodwill has grown at a 0.0% compound annual growth rate (CAGR), from $52M to $52M.
- What does pharma — goodwill mean?
- The carrying value of goodwill associated with the pharmaceutical segment after accounting for any impairment charges. This reflects the current valuation of intangible synergies and market advantages acquired through past business combinations.
Ask your AI about Icahn Enterprises's pharma — goodwill.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude